VOR icon

Vor Biopharma
VOR

Overview Fund Activity

55 hedge funds and large institutions have $481M invested in Vor Biopharma in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 14 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
+4
Holders Change %
+7.84%
% of All Funds
0.97%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
9
Increased
24
Reduced
14
Closed
4
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
+$2K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
$20.4M
2
BlackRock
BlackRock
New York
$17.7M
3
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$3.57M
4
Geode Capital Management
Geode Capital Management
Massachusetts
$4.26M
5
LCM
Laurion Capital Management
New York
$10.3M

Top Sellers

1
SAM
Sectoral Asset Management
Quebec, Canada
$0
2
Fidelity Investments
Fidelity Investments
Massachusetts
$50.3M
3
PI
Putnam Investments
Massachusetts
$3.74M
4
GGHC
Gilder Gagnon Howe & Co
New York
$1.73M
5
TOCUITCONY
Trustees of Columbia University in the City of New York
New York
$1.44M
Name Holding Trade Value Shares
Change 		Shares
Change %
UBS Group
51
UBS Group
Switzerland
$1K -$137K -5,081 -99%
CAPTRUST Financial Advisors
52
CAPTRUST Financial Advisors
North Carolina
$1K +$1K +37 New
PA
53
Parallel Advisors
California
$1K +$455 +40 +83%
SAM
54
Sectoral Asset Management
Quebec, Canada
– -$7.56M -405,324 Closed
NAM
55
Nexpoint Asset Management
Texas
– -$933K -50,000 Closed
Millennium Management
56
Millennium Management
New York
– -$342K -18,339 Closed
EBA
57
Eagle Bay Advisors
New York
– -$3K -150 Closed
1 2
3